These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 32324852)

  • 1. The independent reduction in mortality associated with guideline-directed medical therapy in patients with coronary artery disease and heart failure with reduced ejection fraction.
    Wolfe NK; Mitchell JD; Brown DL
    Eur Heart J Qual Care Clin Outcomes; 2021 Jul; 7(4):416-421. PubMed ID: 32324852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating Guideline Directed Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction Post-coronary Artery Bypass Grafting.
    Kabulski GM; Boughner T; Szymanski TW; Sokos GG; Kido K
    J Pharm Pract; 2023 Dec; 36(6):1370-1374. PubMed ID: 35926866
    [No Abstract]   [Full Text] [Related]  

  • 3. Sex Disparities in Longitudinal Use and Intensification of Guideline-Directed Medical Therapy Among Patients With Newly Diagnosed Heart Failure With Reduced Ejection Fraction.
    Sumarsono A; Xie L; Keshvani N; Zhang C; Patel L; Alonso WW; Thibodeau JT; Fonarow GC; Van Spall HGC; Messiah SE; Pandey A
    Circulation; 2024 Feb; 149(7):510-520. PubMed ID: 38258605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart Failure Hospitalization and Guideline-Directed Prescribing Patterns Among Heart Failure With Reduced Ejection Fraction Patients.
    Srivastava PK; DeVore AD; Hellkamp AS; Thomas L; Albert NM; Butler J; Patterson JH; Spertus JA; Williams FB; Duffy CI; Hernandez AF; Fonarow GC
    JACC Heart Fail; 2021 Jan; 9(1):28-38. PubMed ID: 33309579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality and guideline-directed medical therapy in real-world heart failure patients with reduced ejection fraction.
    McCullough PA; Mehta HS; Barker CM; Van Houten J; Mollenkopf S; Gunnarsson C; Ryan M; Cork DP
    Clin Cardiol; 2021 Sep; 44(9):1192-1198. PubMed ID: 34342033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction.
    Givertz MM; Stevenson LW; Costanzo MR; Bourge RC; Bauman JG; Ginn G; Abraham WT;
    J Am Coll Cardiol; 2017 Oct; 70(15):1875-1886. PubMed ID: 28982501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing Guideline-Directed Medication Therapy for Heart Failure in End-Stage Renal Disease.
    Cutshall BT; Duhart BT; Saikumar J; Samarin M; Hutchison L; Hudson JQ
    Am J Med Sci; 2018 Mar; 355(3):247-251. PubMed ID: 29549927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Background pharmacological therapy in the ANTHEM-HF: comparison to contemporary trials of novel heart failure therapies.
    Premchand RK; Sharma K; Mittal S; Monteiro R; Libbus I; Ardell JL; Gregory DD; KenKnight BH; Amurthur B; DiCarlo LA; Anand IS
    ESC Heart Fail; 2019 Oct; 6(5):1052-1056. PubMed ID: 31339232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guideline-directed medical therapy assessment in heart failure patients undergoing percutaneous mitral valve repair.
    Kresoja KP; Adamo M; Rommel KP; Stolz L; Karam N; Giannini C; Melica B; von Bardeleben RS; Butter C; Horn P; Praz F; Kalbacher D; Iliadis C; Thiele H; Hausleiter J; Metra M; Lurz P
    ESC Heart Fail; 2024 Jun; 11(3):1802-1807. PubMed ID: 38351672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Optimizing Guideline-Directed Medical Therapy Before Discharge on Mortality and Heart Failure Readmission in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction.
    Yamaguchi T; Kitai T; Miyamoto T; Kagiyama N; Okumura T; Kida K; Oishi S; Akiyama E; Suzuki S; Yamamoto M; Yamaguchi J; Iwai T; Hijikata S; Masuda R; Miyazaki R; Hara N; Nagata Y; Nozato T; Matsue Y
    Am J Cardiol; 2018 Apr; 121(8):969-974. PubMed ID: 29477488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polypharmacy and Optimization of Guideline-Directed Medical Therapy in Heart Failure: The GUIDE-IT Trial.
    Khan MS; Singh S; Segar MW; Usman MS; Keshvani N; Ambrosy AP; Fiuzat M; Van Spall HGC; Fonarow GC; Zannad F; Felker GM; Januzzi JL; O'Connor C; Butler J; Pandey A
    JACC Heart Fail; 2023 Nov; 11(11):1507-1517. PubMed ID: 37115133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex Differences in Pharmacotherapy and Long-Term Outcomes in Patients With Ischaemic Heart Disease and Comorbid Left Ventricular Dysfunction.
    Dagan M; Dinh DT; Stehli J; Nan Tie E; Brennan A; Ajani AE; Clark DJ; Freeman M; Reid CM; Hiew C; Oqueli E; Kaye DM; Duffy SJ;
    Heart Lung Circ; 2023 Dec; 32(12):1457-1464. PubMed ID: 37945426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Guideline-Directed Medical Therapy on 10-Year Mortality after Revascularization for Patients with Chronic Limb-Threatening Ischemia.
    Hata Y; Iida O; Okamoto S; Ishihara T; Nanto K; Tsujimura T; Higashino N; Toyoshima T; Kitano I; Tsuji Y; Takahara M; Mano T
    J Atheroscler Thromb; 2023 Jun; 30(6):663-674. PubMed ID: 36031358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modifications of medical treatment and outcome after percutaneous correction of secondary mitral regurgitation.
    Stolfo D; Castrichini M; Biagini E; Compagnone M; De Luca A; Caiffa T; Berardini A; Vitrella G; Korcova R; Perkan A; Foroni M; Merlo M; Barbati G; Saia F; Rapezzi C; Sinagra G
    ESC Heart Fail; 2020 Aug; 7(4):1753-1763. PubMed ID: 32426906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal medical therapy with or without surgical revascularization and long-term outcomes in ischemic cardiomyopathy.
    Farsky PS; White J; Al-Khalidi HR; Sueta CA; Rouleau JL; Panza JA; Velazquez EJ; O'Connor CM;
    J Thorac Cardiovasc Surg; 2022 Dec; 164(6):1890-1899.e4. PubMed ID: 33610365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frailty interferes with the guideline-directed medical therapy in heart failure patients with reduced ejection fraction.
    Hamada T; Kubo T; Kawai K; Nakaoka Y; Yabe T; Furuno T; Yamada E; Kitaoka H;
    ESC Heart Fail; 2023 Feb; 10(1):223-233. PubMed ID: 36193578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Guideline-Directed Medications for Heart Failure Before Cardioverter-Defibrillator Implantation.
    Roth GA; Poole JE; Zaha R; Zhou W; Skinner J; Morden NE
    J Am Coll Cardiol; 2016 Mar; 67(9):1062-1069. PubMed ID: 26940927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of adherence to guideline-directed therapy on risk of death in HF patients across an ejection fraction spectrum.
    Chen X; Kang Y; Dahlström U; Fu M
    ESC Heart Fail; 2023 Dec; 10(6):3656-3666. PubMed ID: 37803813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guideline-Directed Medication Use in Patients With Heart Failure With Reduced Ejection Fraction in India: American College of Cardiology's PINNACLE India Quality Improvement Program.
    Pokharel Y; Wei J; Hira RS; Kalra A; Shore S; Kerkar PG; Kumar G; Risch S; Vicera V; Oetgen WJ; Deswal A; Turakhia MP; Glusenkamp N; Virani SS
    Clin Cardiol; 2016 Mar; 39(3):145-9. PubMed ID: 26880649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial: A Secondary Analysis of a Randomized Clinical Trial.
    Fiuzat M; Ezekowitz J; Alemayehu W; Westerhout CM; Sbolli M; Cani D; Whellan DJ; Ahmad T; Adams K; Piña IL; Patel CB; Anstrom KJ; Cooper LS; Mark D; Leifer ES; Felker GM; Januzzi JL; O'Connor CM
    JAMA Cardiol; 2020 Jul; 5(7):757-764. PubMed ID: 32319999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.